JPY 2240.0
(0.45%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -9.24 Billion JPY | 5.65% |
2022 | -9.8 Billion JPY | -49.08% |
2021 | -6.57 Billion JPY | -15.07% |
2020 | -5.71 Billion JPY | -51.85% |
2019 | -3.76 Billion JPY | 29.43% |
2018 | -5.33 Billion JPY | 2.24% |
2017 | -5.45 Billion JPY | -26.22% |
2016 | -4.32 Billion JPY | 25.4% |
2015 | -5.79 Billion JPY | -11.9% |
2014 | -5.17 Billion JPY | -42.55% |
2013 | -3.63 Billion JPY | -1081.35% |
2012 | 370 Million JPY | -92.74% |
2011 | 5.09 Billion JPY | -25.96% |
2010 | 6.88 Billion JPY | 54.56% |
2009 | 4.45 Billion JPY | -8.8% |
2008 | 4.88 Billion JPY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -9.75 Billion JPY | -5.43% |
2023 FY | -9.24 Billion JPY | 5.65% |
2023 Q2 | -8.67 Billion JPY | 6.86% |
2023 Q4 | -9.24 Billion JPY | -4.62% |
2023 Q3 | -8.84 Billion JPY | -1.91% |
2023 Q1 | -9.31 Billion JPY | 4.99% |
2022 Q4 | -9.8 Billion JPY | -30.94% |
2022 Q3 | -7.48 Billion JPY | 6.84% |
2022 Q1 | -6.58 Billion JPY | -0.12% |
2022 FY | -9.8 Billion JPY | -49.08% |
2022 Q2 | -8.03 Billion JPY | -22.07% |
2021 Q4 | -6.57 Billion JPY | 25.8% |
2021 Q2 | -8.42 Billion JPY | -6.66% |
2021 FY | -6.57 Billion JPY | -15.07% |
2021 Q1 | -7.9 Billion JPY | -38.31% |
2021 Q3 | -8.86 Billion JPY | -5.13% |
2020 FY | -5.71 Billion JPY | -51.85% |
2020 Q1 | -4.92 Billion JPY | -30.83% |
2020 Q2 | -4.06 Billion JPY | 17.51% |
2020 Q3 | -5.38 Billion JPY | -32.65% |
2020 Q4 | -5.71 Billion JPY | -6.07% |
2019 FY | -3.76 Billion JPY | 29.43% |
2019 Q4 | -3.76 Billion JPY | 13.45% |
2019 Q1 | -4.22 Billion JPY | 20.71% |
2019 Q2 | -4.42 Billion JPY | -4.59% |
2019 Q3 | -4.34 Billion JPY | 1.67% |
2018 Q3 | -5.28 Billion JPY | 11.72% |
2018 Q4 | -5.33 Billion JPY | -0.95% |
2018 FY | -5.33 Billion JPY | 2.24% |
2018 Q2 | -5.98 Billion JPY | 2.54% |
2018 Q1 | -6.13 Billion JPY | -12.56% |
2017 FY | -5.45 Billion JPY | -26.22% |
2017 Q4 | -5.45 Billion JPY | -3.41% |
2017 Q3 | -5.27 Billion JPY | -3.01% |
2017 Q2 | -5.12 Billion JPY | -9.45% |
2017 Q1 | -4.67 Billion JPY | -8.26% |
2016 Q2 | -5.18 Billion JPY | 13.43% |
2016 FY | -4.32 Billion JPY | 25.4% |
2016 Q3 | -4.91 Billion JPY | 5.22% |
2016 Q1 | -5.99 Billion JPY | -3.45% |
2016 Q4 | -4.32 Billion JPY | 12.1% |
2015 Q3 | -5.71 Billion JPY | 3.43% |
2015 FY | -5.79 Billion JPY | -11.9% |
2015 Q4 | -5.79 Billion JPY | -1.33% |
2015 Q2 | -5.91 Billion JPY | 5.37% |
2015 Q1 | -6.25 Billion JPY | -20.85% |
2014 Q4 | -5.17 Billion JPY | 22.76% |
2014 Q3 | -6.7 Billion JPY | -14.39% |
2014 Q2 | -5.85 Billion JPY | -25.36% |
2014 Q1 | -4.67 Billion JPY | -28.7% |
2014 FY | -5.17 Billion JPY | -42.55% |
2013 Q2 | -2.79 Billion JPY | -7.95% |
2013 Q1 | -2.59 Billion JPY | -800.0% |
2013 FY | -3.63 Billion JPY | -1081.35% |
2013 Q3 | -7.65 Billion JPY | -173.61% |
2013 Q4 | -3.63 Billion JPY | 52.54% |
2012 Q3 | 622 Million JPY | -59.19% |
2012 Q1 | 2.39 Billion JPY | -53.03% |
2012 Q4 | 370 Million JPY | -40.51% |
2012 Q2 | 1.52 Billion JPY | -36.37% |
2012 FY | 370 Million JPY | -92.74% |
2011 FY | 5.09 Billion JPY | -25.96% |
2011 Q1 | 3.6 Billion JPY | -47.68% |
2011 Q2 | 3.22 Billion JPY | -10.63% |
2011 Q3 | 2.81 Billion JPY | -12.64% |
2011 Q4 | 5.09 Billion JPY | 81.27% |
2010 FY | 6.88 Billion JPY | 54.56% |
2010 Q4 | 6.88 Billion JPY | 956.29% |
2010 Q3 | 652 Million JPY | 44.89% |
2010 Q1 | 1.41 Billion JPY | 0.0% |
2010 Q2 | 450 Million JPY | -68.15% |
2009 FY | 4.45 Billion JPY | -8.8% |
2009 Q3 | 4 Billion JPY | 0.0% |
2008 Q4 | 4.98 Billion JPY | 0.0% |
2008 FY | 4.88 Billion JPY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 16.05 Billion JPY | 157.597% |
DNA Chip Research Inc. | -388.4 Million JPY | -2281.014% |
Cosmo Bio Company,Limited | -2.8 Billion JPY | -229.579% |
H.U. Group Holdings, Inc. | 41.99 Billion JPY | 122.02% |
BML, Inc. | -68.84 Billion JPY | 86.568% |
Human Metabolome Technologies, Inc. | -1.56 Billion JPY | -491.985% |
Precision System Science Co., Ltd. | -548.58 Million JPY | -1585.785% |